Jiaying Lu Selected Research

Alzheimer Disease (Alzheimer's Disease)

12/2023	Influence of Gender on Tau Precipitation in Alzheimer's Disease According to ATN Research Framework.
8/2023	International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease.
2/2023	Based on Tau PET Radiomics Analysis for the Classification of Alzheimer's Disease and Mild Cognitive Impairment.
1/2023	Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
12/2022	Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment.
1/2022	Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET.
1/2021	Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an 18F-AV-45 study.
1/2020	Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism.
1/2019	Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer's disease and mild cognitive impairment.
1/2019	Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiaying Lu Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2018
8	Cognitive Dysfunction 12/2023 - 01/2018
4	Parkinsonian Disorders (Parkinsonism) 01/2025 - 01/2021
4	Neoplasms (Cancer) 08/2023 - 10/2020
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2018
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2024 - 08/2023
2	Esophageal Squamous Cell Carcinoma 08/2023 - 01/2023
2	Dementia (Dementias) 08/2023 - 01/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2019 - 12/2018
2	Fibrosis (Cirrhosis) 02/2019 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2019 - 01/2018
1	Neuroinflammatory Diseases 01/2024
1	Deglutition Disorders (Dysphagia) 01/2024
1	Encephalitis (Encephalitis, Rasmussen) 01/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Rupture 01/2022
1	Disease Progression 01/2022
1	Amyloid Plaque 01/2022
1	REM Sleep Behavior Disorder 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2021
1	Delirium 12/2020
1	Myocardial Infarction 12/2020
1	Tauopathies 01/2020
1	Systemic Scleroderma (Systemic Sclerosis) 02/2019
1	Nerve Degeneration 01/2019
1	Pneumonia (Pneumonitis) 12/2018

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 01/2019
3	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2023
2	tau Proteins (tau Protein)IBA 12/2023 - 02/2023
2	Programmed Cell Death 1 ReceptorIBA 08/2023 - 01/2023
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 01/2021
2	CollagenIBA 02/2019 - 01/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2019 - 01/2017
2	salvianolic acid BIBA 02/2019 - 12/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2025
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2024
1	1,3-dipropyl-8-phenylxanthineIBA 01/2024
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	B7-H1 AntigenIBA 09/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Free RadicalsIBA 06/2023
1	Anthocyanins (Anthocyanin)IBA 06/2023
1	Oxygen (Dioxygen)IBA 06/2023
1	OzoneIBA 01/2023
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Nonprescription Drugs (Patent Medicines)IBA 01/2021
1	florbetapirIBA 01/2021
1	3,6-dimethylaminodibenzopyriodonium citrateIBA 01/2021
1	molybdenum disulfideIBA 10/2020
1	GraphiteIBA 10/2020
1	CytokinesIBA 12/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	alpha2 Subunit Collagen Type IIBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017

Therapy/Procedure

3	Chemoradiotherapy 09/2023 - 01/2023
2	Therapeutics 08/2023 - 10/2020
1	Immunotherapy 09/2023
1	Drug Therapy (Chemotherapy) 08/2023
1	Radiotherapy 01/2023
1	Percutaneous Coronary Intervention 12/2020
1	Photothermal Therapy 10/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2019